Literature DB >> 11438456

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

S Aractingi1, N Briand, C Le Danff, M Viguier, H Bachelez, L Michel, L Dubertret, E D Carosella.   

Abstract

Recent data have suggested that in psoriasis, the T-infiltrating cells could be submitted to regulatory pathways, possibly through natural killer receptors. HLA-G binds to different natural killer receptors and is able to inhibit T-cell functions. Because this molecule is induced by interferon-gamma, a major cytokine in psoriasis, we asked whether HLA-G and its receptor might be expressed in this disease. Specific RNAs for HLA-G1 and HLA-G5 were consistently found in lesional skin specimens, soluble HLA-G5 transcripts being found only in psoriasis. HLA-G protein was found in all psoriatic sections, but never in normal skin controls. Double labeling demonstrated that HLA-G-positive cells were CD68(+), CD11c(+) macrophages. The NKR ILT2 was also present in psoriatic skin, the T CD4(+)-infiltrating cells expressing indeed ILT2. The demonstration of HLA-G and ILT2 expression in psoriatic skin suggests that this pathway may act as an inhibitory feed back aimed to down-regulate the deleterious effects of T-cell infiltrate in this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438456      PMCID: PMC1850403          DOI: 10.1016/S0002-9440(10)61675-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

Review 1.  Skin innate immune system in psoriasis: friend or foe?

Authors:  B J Nickoloff
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma.

Authors:  S N Wagner; V Rebmann; C P Willers; H Grosse-Wilde; M Goos
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

3.  Epithelium-lining macrophages in psoriasis.

Authors:  J J van den Oord; C de Wolf-Peeters
Journal:  Br J Dermatol       Date:  1994-05       Impact factor: 9.302

4.  Clearance of psoriasis with low dose cyclosporin.

Authors:  C E Griffiths; A V Powles; J N Leonard; L Fry; B S Baker; H Valdimarsson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

Review 5.  Treatment of psoriasis.

Authors:  M W Greaves; G D Weinstein
Journal:  N Engl J Med       Date:  1995-03-02       Impact factor: 91.245

6.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.

Authors:  P Paul; N Rouas-Freiss; I Khalil-Daher; P Moreau; B Riteau; F A Le Gal; M F Avril; J Dausset; J G Guillet; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.

Authors:  D Saverino; M Fabbi; F Ghiotto; A Merlo; S Bruno; D Zarcone; C Tenca; M Tiso; G Santoro; G Anastasi; D Cosman; C E Grossi; E Ciccone
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  T cells involved in psoriasis vulgaris belong to the Th1 subset.

Authors:  J F Schlaak; M Buslau; W Jochum; E Hermann; M Girndt; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Invest Dermatol       Date:  1994-02       Impact factor: 8.551

9.  T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation.

Authors:  P Strange; K D Cooper; E R Hansen; G Fisher; J K Larsen; D Fox; C Krag; J J Voorhees; O Baadsgaard
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

10.  HLA-G: expression in human keratinocytes in vitro and in human skin in vivo.

Authors:  M Ulbrecht; B Rehberger; I Strobel; G Messer; P Kind; K Degitz; T Bieber; E H Weiss
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

View more
  36 in total

Review 1.  HLA-G: a look back, a look forward.

Authors:  Edgardo D Carosella; Joel LeMaoult
Journal:  Cell Mol Life Sci       Date:  2010-11-19       Impact factor: 9.261

Review 2.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

3.  Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.

Authors:  Kiave-Yune HoWangYin; Maria Loustau; Juan Wu; Estibaliz Alegre; Marina Daouya; Julien Caumartin; Sylvie Sousa; Anatolij Horuzsko; Edgardo D Carosella; Joel LeMaoult
Journal:  Cell Mol Life Sci       Date:  2012-07-17       Impact factor: 9.261

4.  Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals.

Authors:  Jerzy K Kulski; William Kenworthy; Matthew Bellgard; Ross Taplin; Koichi Okamoto; Akira Oka; Tomotaka Mabuchi; Akira Ozawa; Gen Tamiya; Hidetoshi Inoko
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

5.  Role and expression of non-classical human leukocyte antigen-G in renal transplanted allografts.

Authors:  Sho Kumano; Yuki Okushi; Keiji Fujimoto; Hiroki Adachi; Kengo Furuichi; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2021-01-04       Impact factor: 2.801

6.  HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells.

Authors:  Joël LeMaoult; Irène Krawice-Radanne; Jean Dausset; Edgardo D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-21       Impact factor: 11.205

Review 7.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

8.  In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.

Authors:  Philippe Rousseau; Krzysztof Masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

9.  HLA-G does not have a pathophysiological role in Graves' disease.

Authors:  E H Kemp; R A Metcalfe; P F Watson; A P Weetman
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

10.  HLA-G gene repression is reversed by demethylation.

Authors:  Philippe Moreau; Gael Mouillot; Philippe Rousseau; Celine Marcou; Jean Dausset; Edgardo D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.